Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US

Drug firm Lupin on Monday said it has launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XcInlH
via IFTTT